Stacey L Martiniano
Overview
Explore the profile of Stacey L Martiniano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Poore T, Meier M, Towler E, Martiniano S, Brinton J, DeBoer E, et al.
Pediatr Pulmonol
. 2021 Oct;
57(1):152-161.
PMID: 34687280
Background: Individuals with cystic fibrosis (CF) and fungal airway infection may present with fungal bronchitis, allergic bronchopulmonary aspergillosis (ABPA) or may appear unaffected despite fungal detection. We sought to characterize...
12.
Hasan N, Davidson R, Epperson L, Kammlade S, Beagle S, Levin A, et al.
Emerg Infect Dis
. 2021 Oct;
27(11):2836-2846.
PMID: 34670648
Mycobacterium avium complex (MAC) species constitute most mycobacteria infections in persons with cystic fibrosis (CF) in the United States, but little is known about their genomic diversity or transmission. During...
13.
Gross J, McCown M, Okorie C, Bishay L, Dy F, Astudillo C, et al.
ATS Sch
. 2021 Oct;
2(3):452-467.
PMID: 34667993
The following is a concise review of the Pediatric Pulmonary Medicine Core reviewing pediatric pulmonary infections, diagnostic assays, and imaging techniques presented at the 2021 American Thoracic Society Core Curriculum....
14.
Martiniano S, Croak K, Bonn G, Sontag M, Sagel S
Mol Genet Metab
. 2021 Sep;
134(1-2):65-67.
PMID: 34489170
The Colorado Newborn Screening Program (CO-NBS) screens for cystic fibrosis (CF) by measuring immunoreactive trypsinogen (IRT) from two screens coupled with DNA analysis (IRT/IRT/DNA). The Colorado CF Care Center identified...
15.
Martiniano S, Elbert A, Farrell P, Ren C, Sontag M, Wu R, et al.
Pediatr Pulmonol
. 2021 Sep;
56(12):3758-3767.
PMID: 34469079
Introduction: Newborn screening (NBS) for cystic fibrosis (CF) was implemented in all US states and DC by 2010. This hypothesis-generating study was designed to form the basis of additional analyses...
16.
Holsteen P, Meier M, Brennan L, VanHorn T, Kuldanek S, Wang M, et al.
Thromb Res
. 2021 Aug;
206:36-41.
PMID: 34399123
Background: People with cystic fibrosis (CF) have an increased risk of thrombosis due to acquired thrombophilia secondary to chronic systemic inflammation and central venous catheter use for treatment of pulmonary...
17.
Martiniano S, Wagner B, Brennan L, Wempe M, Anderson P, Daley C, et al.
J Cyst Fibros
. 2021 May;
20(5):772-778.
PMID: 34030986
Background: Treatment failure of Mycobacterium avium complex (MAC) pulmonary disease occurs in about 30% of people with cystic fibrosis (CF) and may be a result of abnormal drug concentrations. Methods:...
18.
Sontag M, Farrell P, Kellar-Guenther Y, Martiniano S, Miller J, Ren C, et al.
J Cyst Fibros
. 2021 May;
20(4):717-718.
PMID: 34020895
No abstract available.
19.
Davidson R, Hasan N, Epperson L, Benoit J, Kammlade S, Levin A, et al.
Ann Am Thorac Soc
. 2021 Apr;
18(12):1960-1969.
PMID: 33856965
is a significant threat to individuals with cystic fibrosis (CF) because of innate drug resistance and potential transmission between patients. Recent studies described global dominant circulating clones of , but...
20.
Lenhart-Pendergrass P, Anthony M, Sariyska S, Andrews A, Scavezze H, Towler E, et al.
Pediatr Pulmonol
. 2021 Apr;
56(7):2043-2047.
PMID: 33847465
Background: Collection of respiratory cultures for airway microbiology surveillance is an essential component of routine clinical care in cystic fibrosis (CF). The COVID-19 global pandemic has necessitated increased use of...